RK

Ranbir Kaur

Active Director Director DIN 10088123
DIN 10088123 First appointment Mar 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Ranbir Kaur

Data last updated:

Ranbir Kaur is a Director at Mosanto Pharma Private Limited (since 2023). The company operates in Paper. Mosanto Pharma Private Limited reported revenue of ₹1.2 Lakh (FY 2025).

DIN 10088123
Primary Designation Director
Industry Paper
First Appointment 25 Mar 2023
Oldest Company Age 3 yrs
Largest company Mosanto Pharma Private Limited · ₹1.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mosanto Pharma Private Limited U21009UP2023PTC178918
Director25 Mar 20232023₹1.2 Lakh (FY 2025)Active

Board colleagues of Ranbir Kaur

NameDINCompanyDesignation
Usha Varma10088122Mosanto Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mosanto Pharma Private Limited
Premium access

Shareholding and investment profile for Ranbir Kaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranbir Kaur

Ranbir Kaur currently holds 1 directorship: Mosanto Pharma Private Limited (Director, since 25 Mar 2023, revenue ₹1.2 Lakh (FY 2025)).

Ranbir Kaur was first appointed on 25 Mar 2023 as Director at Mosanto Pharma Private Limited.

The current boards of Ranbir Kaur's companies include Usha Varma (Mosanto Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available